NCT05236296

Brief Summary

The purpose of this study is to test the feasibility and acceptability of an adapted psychosocial intervention, called Emotion and Symptom-focused Engagement for Caregivers (EASE-CG), to reduce traumatic stress symptoms and other psychological distress and increase well-being in primary caregivers of patients newly diagnosed with acute leukemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 11, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

April 12, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 17, 2025

Status Verified

July 1, 2025

Enrollment Period

2.7 years

First QC Date

February 1, 2022

Last Update Submit

July 14, 2025

Conditions

Keywords

CaregiversPsychosocial InterventionTraumatic StressHematological MalignanciesSupportive CareAcute Leukemia

Outcome Measures

Primary Outcomes (2)

  • Stanford Acute Stress Reaction Questionnaire (SASRQ-II)

    A 30-item reliable, valid, and widely used self-report measure assessing the severity of traumatic stress symptoms over the past four weeks. Total SASRQ scores may range from 0-150, with higher scores indicating increasingly severe traumatic stress symptoms. This measure has been updated to be Diagnostic and Statistical Manual of Mental Disorders (DSM-5)-concordant for acute stress disorder symptoms.

    12 weeks

  • PTSD Checklist for DSM-5 (PCL-5)

    A 20-item reliable and valid self-report measure of the presence and severity of post-traumatic stress disorder (PTSD) symptoms over the past month. Total PCL-5 scores may range from 0-80, with higher scores indicating increasingly severe PTSD symptoms. This DSM-5-concordant measure has been included to help validate the DSM-5-concordant version of the SASRQ.

    12 weeks

Secondary Outcomes (6)

  • Brief Experiences in Close Relationships Scale (ECR-M16)

    12 weeks

  • Patient Health Questionnaire-9 (PHQ-9)

    12 weeks

  • Caregiver Reaction Assessment (CRA) Scale

    12 weeks

  • Enhancing Recovery In Coronary Heart Disease (ENRICHD) Social Support Inventory (ESSI)

    12 weeks

  • Family Satisfaction with End-of-Life Care (FAMCARE) Scale

    12 weeks

  • +1 more secondary outcomes

Study Arms (1)

EASE-CG Intervention

EXPERIMENTAL

Participants will be offered one EASE-CG therapy session every week for up to 12 weeks. Each session will last for approximately 30-60 minutes, delivered by a trained therapist at our center. Frequency and/or length of sessions may vary to accommodate the needs and availability of each participant. Outcomes will be assessed at baseline, 1, 3, 6, 9, and 12 months. Participants may be invited to brief, semi-structured interviews.

Behavioral: EASE-CG

Interventions

EASE-CGBEHAVIORAL

EASE-CG is an adapted brief psychotherapeutic intervention with relational support and trauma-based cognitive behavioral therapy (CBT) components.

EASE-CG Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-identified primary caregiver (i.e., person assuming the majority of care activities) or co-primary caregiver (i.e., assuming at least 40% of care activities alongside another co-primary caregiver) of an adult or pediatric patient who is newly diagnosed with acute leukemia within 3 months of admission to the Princess Margaret Cancer Centre or the Hospital for Sick Children
  • Age ≥18 years
  • Fluency in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Hospital for Sick Children

Toronto, Ontario, M5G 1X8, Canada

Location

Princess Margaret Cancer Centre

Toronto, Ontario, M5G 2M9, Canada

Location

Related Publications (2)

  • Rodin G, Malfitano C, Rydall A, Schimmer A, Marmar CM, Mah K, Lo C, Nissim R, Zimmermann C. Emotion And Symptom-focused Engagement (EASE): a randomized phase II trial of an integrated psychological and palliative care intervention for patients with acute leukemia. Support Care Cancer. 2020 Jan;28(1):163-176. doi: 10.1007/s00520-019-04723-2. Epub 2019 Apr 17.

    PMID: 31001692BACKGROUND
  • Jibb LA, Yu A, Nanos S, Malfitano C, Foran L, Hunt K, Malakian A, Zimmermann C, Schultebraucks K, Pham NA, Rydall A, Alexander S, Rodin G. The Emotion and Symptom-Focused Engagement (EASE) Psychotherapeutic Intervention for Parents of Children With Acute Leukemia: A Feasibility Trial. Psychooncology. 2025 Nov;34(11):e70310. doi: 10.1002/pon.70310.

MeSH Terms

Conditions

LeukemiaHematologic Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesNeoplasms by Site

Study Officials

  • Gary Rodin, MD FRCPC

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR
  • Lindsay Jibb, RN PhD

    The Hospital for Sick Children

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: All study participants will receive the EASE-CG intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2022

First Posted

February 11, 2022

Study Start

April 12, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

July 17, 2025

Record last verified: 2025-07

Locations